Implements Bayesian phase I repeated measurement design that accounts for multidimensional toxicity endpoints and longitudinal efficacy measure from multiple treatment cycles and allows individualized dose modification. The package provides a number of model-based phase I designs, including 1 stage models with or without individualized dose modification, 3-stage models with or without individualized dose modification, etc. Functions are provided to recommend dosage selection based on the data collected in the available patient cohorts and to simulate trial characteristics given design parameters.


This package can be installed directly from R by running the following code:




Detailed manual will relase in the near future

Try the phase1PRMD package in your browser

Any scripts or data that you put into this service are public.

phase1PRMD documentation built on May 1, 2019, 9:26 p.m.